Paratek Pharmaceuticals, Inc.

PRTKNASDAQHealthcare

$2.23

+$0.04(+1.83%)

Market Cap$127828952

P/E Ratio—

52W High$3.65

52W Low$1.29

Avg Volume631K

Open$2.19

Beta1.70

Overview

Paratek Pharmaceuticals, Inc. (PRTK) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

PRTK · cash on hand · updated Dec 31, 2022

Core cash position

as of Dec 31, 2022

Cash & Short-Term Investments (CCE + ST Investments)

$34.2M▼ -64.1% vs prior year

FY · as of Dec 31, 2022 · Reported in USD

Cash & Cash Equiv. (CCE)

$34.2M

cashAndCashEquivalents

Short-Term Investments

shortTermInvestments

YoY Change vs Prior Year

-64.1%

vs prior fiscal year

Latest Quarter

$42.7M

Q2 2023

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2022

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$34.2MCash on Hand

Total Debt$258.4MTotal Debt

Net Cash / Net Debt−$224.2MNet Debt Position

Cash vs Debt Ratio

Cash 12%Paratek Pharmaceuticals, Inc. cash as % of market cap: 26.79%% · MCap $0BDebt 88%

Paratek Pharmaceuticals, Inc. carries a net debt position of $224.2M. Total debt ($258.4M) exceeds cash on hand ($34.2M). Paratek Pharmaceuticals, Inc. cash vs debt ratio: 12% cash / 88% debt.

Net Cash = Cash & ST Investments − Total Debt$34.2M − $258.4M = −$224.2M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

PRTK annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

PRTK cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2022LatestFY$34.2M-64.1%

Dec 31, 2021FY$95.5M-23.7%

Dec 31, 2020FY$125.2M-41.9%

Dec 31, 2019FY$215.4M-26.5%

Dec 31, 2018FY$292.8M+93.0%

PRTK cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

PRTK vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Paratek Pharmaceuticals, Inc.YOU

PRTK

$34.2M$128M26.8%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Paratek Pharmaceuticals, Inc. (PRTK) cash on hand as of December 31, 2022 is $34.2M, comprising $34.2M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Paratek Pharmaceuticals, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Paratek Pharmaceuticals, Inc. cash reserves or cash position.

Paratek Pharmaceuticals, Inc. annual cash on hand history shows decreased -64.1% in 2022: decreased -64.1% in 2022. Paratek Pharmaceuticals, Inc. cash reserves in 2022 reflect the company's capital allocation strategy.

Paratek Pharmaceuticals, Inc. carries total debt of $258.4M against cash of $34.2M, resulting in a net debt position of -$224.2M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

PRTK cash on hand · 5 questions

As of December 31, 2022, Paratek Pharmaceuticals, Inc. (PRTK) has $34,248,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $34,248,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (June 30, 2023): $42,685,000. Data sourced from the annual 10-K filing via FMP.

PRTK cash on handPRTK cash reservesPRTK cash 2022how much cash does PRTK have

▸ Source: FMP /balance-sheet-statement · US GAAP · Paratek Pharmaceuticals, Inc. · Paratek Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2022